Ginkgo Bioworks Holdings, Inc.

DNA · NYSE

Ginkgo Bioworks Holdings, Inc.DNA · NYSE

Regular Market · Oct 30, 07:07 PM

$10.69-$2.05 -16.06%

High: —
Low: —
Volume: —

Loading chart…

Ask Alva about DNA

Ginkgo Bioworks Holdings, Inc.

DNA · Biotechnology

10.69 USD

-2.05 (-16.06%)

Regular Market

High
Low
Volume
Open
Prev Close
Turnover
Trailing P/E
Market Cap
Turnover Ratio
Free Float
Post-Market
VWAP
Range (%)
Volume Ratio
52-Wk High
52-Wk Low
Forward P/E
Beta

Ginkgo Bioworks Holdings, Inc.

DNA · NYSE

Regular Market

10.69 USD

-2.05 (-16.06%)

High
Low
Volume
Open
Prev Close
Turnover
Trailing P/E
Market Cap
Turnover Ratio
Free Float
Post-Market
VWAP
Range (%)
Volume Ratio
52-Wk High
52-Wk Low
Forward P/E
Beta

Unusual Price Movement

DNA extended its risk-off selloff as the Nasdaq slump deepened and synthetic-biology peers dropped sharply.

No new catalyst drove the deeper decline. DNA fell about 13.8%, extending the earlier broad risk-off move as the Nasdaq dropped 2.6% and volatility jumped; TWST and TXG also sold off sharply. Short-selling commentary added pressure to DNA. source

x.com

Unusual Price Movement

DNA extended its risk-off selloff as the Nasdaq slump deepened and synthetic-biology peers dropped sharply.

Sources:

@Short_Sq_Corner: Best short entry I can find Right now - Ginko Bioworks ($DNA)

Ask Alva anything. @ for context, / for skills

Ask Alva about DNA

DNA extended its risk-off selloff as the Nasdaq slump deepened and synthetic-biology peers dropped sharply. ⓘ

DNA extended its risk-off selloff as the Nasdaq slump deepened and synthetic-biology peers dropped sharply. ⓘ

DNA extended its risk-off selloff as the Nasdaq slump deepened and synthetic-biology peers dropped sharply.

DNA extended its risk-off selloff as the Nasdaq slump deepened and synthetic-biology peers dropped sharply.